The US Patent and Trademark Office has granted a patent to Florida-based Valensa International covering its commercial its EyePro MD formula. The formula includes lutein, zeaxanthin and astaxanthin mixed with omega-3 essential oils from krill, algae or perilla seed, said the company in a press release. Patent No. 9,610,313, titled “Eye Health Composition and Method […]
Read More »Parry Nutraceuticals and Synthite Industries Forge Partnership for Phycocyanin Extraction CHENNAI, India (22 June 2017) — Parry Nutraceuticals, a division of E.I.D. Parry and part of the Murugappa Group, has forged a partnership with Synthite Industries to apply proprietary patented technologies for extraction of Phycocyanin, a natural blue pigment found in Spirulina. Natural Blue is one […]
Read More »ORLANDO, FL (8 May 2017) – Parry Nutraceuticals, a division of E.I.D Parry, a global leader in microalgae-based nutraceuticals, announced today that its Organic Spirulina and Chlorella cultivation and processing facility, located in Oonaiyur, Pudukottai District, Tamil Nadu, India has formally received an Establishment Inspection Report (EIR). This is pursuant to the successful inspection of […]
Read More »Certifications from The International Center for Integrative Systems Grows Market Opportunities for Industry-Leading Superfood Orlando, FL 30 January 2017 – Valensa International (Eustis, FL USA) announced today that its Parry Organic Spirulina Ingredient has received Certified R.A.W.TM and Certified C.L.E.A.N.TM status from the raw foods industry standards body, The International Center for Integrative Systems. The […]
Read More »Top-Selling US Brand Sets Industry Standards for Quality, Stability and Taste Advanced, Patented Processing Technology Orlando, FL 21 November 2016 – Valensa International announced today that it has begun offering its Chia Gold Stabilized Chia Seed Oil in Europe. The company gained Novel Food approval for the ingredient via a substantial equivalence opinion in September […]
Read More »Company Has Successfully Completed In-vitro Clinical Trial Work and is Now Advancing into Human Clinical Trials on Immunum™ Line Orlando, FL 17 January 2017 – Valensa International (Eustis, FL USA) announced today that it has reached an agreement with Algal Scientific Corporation (Plymouth, MI USA) to commercialize Algal’s PureAlgalTM branded ingredients – whole dried microalgae (Euglena […]
Read More »